ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Nasal Polyps
Rhinitis
Rhinosinusitis
Chronic Obstructive Pulmonary Disease
Lung Diseases

Asthma trials near Aurora, CO, USA:

Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (PANDA)

This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....

Enrolling
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Aurora, Colorado, United States and 6 other locations

28-week Phase 3 Efficacy and Safety Study of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma...

Enrolling
Asthma
Other: Placebo
Biological: Tezepelumab

Phase 3

AstraZeneca
AstraZeneca

Denver, Colorado, United States and 121 other locations

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Denver, Colorado, United States of America and 122 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Enrolling
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Aurora, Colorado, United States and 209 other locations

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...

Enrolling
Asthma
Drug: Biological: Solrikitug High Dose
Drug: Biological: Solrikitug Mid Dose

Phase 2

Uniquity One (UNI)

Englewood, Colorado, United States and 22 other locations

validation of a wireless, wearable device (Leo) for assessing clinical control of children recovering from acute respiratory event such as asthma...

Enrolling
Asthma in Children
Device: Leo device monitoring
ResMed
ResMed

Aurora, Colorado, United States

The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....

Enrolling
Asthma
Drug: BDA MDI HFO 160/180 μg
Drug: BDA MDI HFA 160/180 μg

Phase 3

AstraZeneca
AstraZeneca

Englewood, Colorado, United States and 130 other locations

BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...

Enrolling
Asthma
Drug: AZD4604
Other: Placebo

Phase 2

AstraZeneca
AstraZeneca

Denver, Colorado, United States and 158 other locations

variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...

Active, not recruiting
Asthma
Drug: BFF pMDI 320/9 μg
Drug: BGF MDI 320/14.4/9.6 μg

Phase 3

AstraZeneca
AstraZeneca

Wheat Ridge, Colorado, United States and 318 other locations

of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...

Active, not recruiting
Asthma
Biological: GSK3511294 (Depemokimab)
Biological: Mepolizumab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Aurora, Colorado, United States and 419 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems